The healthcare and life sciences sectors are now bracing for global ripple effects as the Trump administration, under President Donald J. Trump’s second term, enforces a new round of tariffs targeting imports from key trade partners, including India and China. The proposed 25% tariff on
7th International Conference on ‘India Pharma & India Medical Device 2022’ from April 25-27, 2022 Dr Mansukh Mandaviya, Union Minister for Chemicals & Fertilizers, & Health and Family Welfare, Government of India today said that to meet the critical requirements of the country, India’s dependency
